Highly concentrated, nanoclusters of self-crowded monoclonal antibodies for low viscosity, subcutaneous injections
Delivery of protein therapeutics is restricted to intravenous infusions due to protein-dependent problems including low solubilities, high viscosities, and physical instabilities. The ability to inject high concentrations of proteins via subcutaneous injections would increase accessibility and compl...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/ETD-UT-2011-05-2662 |